An in-depth article authored by Florida Cancer Specialists & Research Institute, LLC (FCS) pharmacy experts published in the American Journal of Managed Care® (AJMC®) issues a call to action for the development of improved metrics to help lower costs and better assess the performance of pharmacies that dispense oral oncolytic medications.
A collaboration between Florida Cancer Specialists & Research Institute, LLC (FCS) and Florida Blue, the state’s Blue Cross Blue Shield plan, is proving to enhance patient care and well-being while also keeping health care costs under control.
Florida Cancer Specialists & Research Institute, LLC (FCS) Fort Myers – Colonial lab team has met all the criteria for Laboratory Accreditation by COLA Inc., a leading national laboratory accreditor, whose program and standards enable clinical laboratories and staff to meet United States Clinical Laboratory Improvement Act (CLIA) and other regulatory requirements.
Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes two Board-certified medical oncologists to the statewide practice, expanding care for patients receiving treatment for cancer and blood disorders. Joining FCS on August 1, 2022 are Tony J. Kurian, MD (Sarasota County) and Wenqing Zhang, MD, PhD (Citrus County).
Rhone M. Levin, M.Ed., RDN, CSO, LDN, FCS clinical oncology dietitian, has been selected to speak at the Pathways to Prevention workshop hosted this month by the National Institutes of Health.
FCS announced the addition of precision oncology capabilities comprised of geneticists, informatics specialists, and database technologies. Enhancing care through molecular data analysis.